OTC Markets OTCPK - Delayed Quote USD

Evofem Biosciences, Inc. (EVFM)

0.0080
-0.0004
(-4.76%)
At close: May 13 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
19,363
19,363
18,218
16,837
8,244
Cost of Revenue
3,834
3,834
6,512
4,415
4,055
Gross Profit
15,529
15,529
11,706
12,422
4,189
Operating Expense
23,205
23,205
29,553
96,546
170,990
Operating Income
-7,676
-7,676
-17,847
-84,124
-166,801
Net Non Operating Interest Income Expense
16
16
31
85
15
Other Income Expense
-1,200
-1,200
70,812
7,385
-38,389
Pretax Income
-8,860
-8,860
52,996
-76,654
-205,175
Tax Provision
0
0
17
44
17
Net Income Common Stockholders
-8,965
-8,965
49,995
-78,014
-206,239
Diluted NI Available to Com Stockholders
-8,965
-8,965
49,995
-78,014
-206,239
Basic EPS
-0.12
--
10.36
-167.50
-2.96k
Diluted EPS
-0.12
--
0.05
-167.50
-2.96k
Basic Average Shares
75,195.6150
--
4,826.7630
465.9840
69.8180
Diluted Average Shares
75,195.6150
--
984,038.5740
465.9840
69.8180
Total Operating Income as Reported
-7,676
-7,676
-17,847
-84,124
-166,801
Total Expenses
27,039
27,039
36,065
100,961
175,045
Net Income from Continuing & Discontinued Operation
-8,860
-8,860
52,979
-76,698
-205,192
Normalized Income
-10,235
-10,235
-20,437.4420
-84,180.8800
-180,622.3900
Interest Income
16
16
31
85
15
Net Interest Income
16
16
31
85
15
EBIT
-7,676
-7,676
-17,847
-84,124
-166,801
EBITDA
-6,920
-6,920
-16,066
-82,078
-165,778
Reconciled Cost of Revenue
3,697
3,697
4,731
4,415
4,055
Reconciled Depreciation
756
756
1,781
2,046
1,023
Net Income from Continuing Operation Net Minority Interest
-8,860
-8,860
52,979
-76,698
-205,192
Total Unusual Items Excluding Goodwill
1,375
1,375
73,440
9,472
-33,657
Total Unusual Items
1,375
1,375
73,440
9,472
-33,657
Normalized EBITDA
-8,295
-8,295
-89,506
-91,550
-132,121
Tax Rate for Calcs
0
0
0
0.0002
0.0003
Tax Effect of Unusual Items
0
0
23.5580
1,989.1200
-9,087.3900
12/31/2021 - 11/20/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ADTX Aditxt, Inc.
1.6300
-8.94%
 
WINT Windtree Therapeutics, Inc.
0.8988
-1.17%
 
GOVXW GeoVax Labs, Inc.
0.0312
-30.67%
 
ACTU Actuate Therapeutics, Inc. Common stock
9.64
-7.75%
 
RNAC Cartesian Therapeutics, Inc.
10.20
-2.30%
 
NLSP NLS Pharmaceutics AG
1.6301
+0.01%
 
COYA Coya Therapeutics, Inc.
5.76
-6.19%
 
LPTX Leap Therapeutics, Inc.
0.4000
+6.64%
 
ESLAW Estrella Immunopharma, Inc.
0.0680
-19.24%
 
JSPRW Jasper Therapeutics, Inc.
0.0875
+0.34%